TEANNA DAPONTE: Open Payments
NPI 1669128534 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$661 in 22 payments from 12 companies in 2025. Trend: 2023 $819 · 2024 $246 · 2025 $661
Food & beverage: $661
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $148 |
| Genentech USA, Inc. | 4 | $102 |
| Legend Biotech USA Inc. | 3 | $93 |
| Invivyd Inc | 3 | $70 |
| Janssen Scientific Affairs, LLC | 2 | $60 |
| Stemline Therapeutics Inc. | 2 | $43 |
| UROGEN PHARMA, INC. | 1 | $34 |
| Incyte Corporation | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Secura Bio, Inc. | 1 | $24 |
Products named: EPKINLY, CARVYKTI, PEMGARDA, TECVAYLI, Polivy, ELZONRIS, ZUSDURI, Venclexta.
Industry payments across FL — which companies pay providers there.
